As of 1:30 PM on the 21st, Jinwon Life Sciences is trading at 27,100 KRW, down 3.39% from the previous day. This marks a 36.08% decline compared to September 22. Jinwon Life Sciences is known as a company specializing in the development of gene therapies and gene vaccines.

Today, foreigners are tentatively recorded as net sellers of 50,000 shares. Over the past five days, individual investors have net sold 110,208 shares, while foreigners and institutions have net bought 143,055 shares and net sold 8,262 shares, respectively.


On October 16, Jinwon Life Sciences became a market issue with a 6% increase following a mention by President Moon.





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing